| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Patient Capital Management, LLC | 18.17M (12.08%) | 721.20K Increased by +3.97% | Jun 30, 24 |
| 2 | Patients Capital Management LLC | 16.27M (10.81%) | -1.10M Decreased by -6.78% | Jun 30, 25 |
| 3 | Adage Capital Partners Gp LLC | 11.28M (7.49%) | 410.60K Increased by +3.64% | Mar 31, 25 |
| 4 | BlackRock Inc | 10.75M (7.15%) | 375.57K Increased by +3.49% | Mar 31, 25 |
| 5 | Vanguard Group Inc | 9.07M (6.03%) | 274.07K Increased by +3.02% | Jun 30, 25 |
| 6 | Iridian Asset Management LLC | 4.59M (3.05%) | -656.11K Decreased by -14.31% | Mar 31, 25 |
| 7 | Geode Capital Management, LLC | 3.48M (2.31%) | 179.75K Increased by +5.17% | Mar 31, 25 |
| 8 | State Street Corp | 3.04M (2.02%) | 64.16K Increased by +2.11% | Mar 31, 25 |
| 9 | State Street Corporation | 2.83M (1.88%) | 140.92K Increased by +4.99% | Mar 31, 24 |
| 10 | Schonfeld Strategic Advisors LLC | 2.79M (1.86%) | 2.79M Increased by +100.00% | Mar 31, 25 |
| 11 | Parkman Healthcare Partners LLC | 1.54M (1.03%) | -1.65M Decreased by -106.85% | Jun 30, 25 |
| 12 | Millennium Management LLC | 1.37M (0.91%) | -1.48M Decreased by -107.66% | Mar 31, 24 |
| 13 | Charles Schwab Investment Management Inc | 1.27M (0.84%) | 53.93K Increased by +4.24% | Jun 30, 25 |
| 14 | Northern Trust Corp | 1.13M (0.75%) | -42.11K Decreased by -3.74% | Mar 31, 25 |
| 15 | Morgan Stanley - Brokerage Accounts | 1.03M (0.69%) | -86.50K Decreased by -8.37% | Mar 31, 25 |
| 16 | Opaleye Management Inc | 947.50K (0.63%) | -65.00K Decreased by -6.86% | Mar 31, 24 |
| 17 | JPMorgan Chase & Co | 813.31K (0.54%) | -31.84K Decreased by -3.92% | Mar 31, 25 |
| 18 | Renaissance Technologies Corp | 792.80K (0.53%) | -274.84K Decreased by -34.67% | Mar 31, 25 |
| 19 | CI Private Wealth LLC | 714.69K (0.47%) | 100.72K Increased by +14.09% | Mar 31, 25 |
| 20 | Susquehanna International Group, LLP | 704.89K (0.47%) | 655.11K Increased by +92.94% | Dec 31, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Patient Opportunity C | 12.80M (8.51%) | -800.00K Decreased by -6.25% | Jun 30, 25 |
| 2 | Vanguard US Total Market Shares ETF | 5.45M (3.62%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 3 | Vanguard Total Stock Mkt Idx Inv | 5.34M (3.55%) | -117.52K Decreased by -2.20% | Jul 31, 25 |
| 4 | iShares Russell 2000 ETF | 3.64M (2.42%) | -69.09K Decreased by -1.90% | Jul 31, 25 |
| 5 | Vanguard Institutional Extnd Mkt Idx Tr | 1.62M (1.08%) | -704.57K Decreased by -43.40% | Jul 31, 25 |
| 6 | Fidelity Small Cap Index | 1.38M (0.91%) | 0.00 Increased by 0.00% | May 31, 25 |
| 7 | Fidelity® Small Cap Index | 1.30M (0.87%) | 31.65K Increased by +2.43% | Oct 31, 23 |
| 8 | iShares Russell 2000 Growth ETF | 1.27M (0.84%) | 0.00 Increased by 0.00% | Jul 31, 25 |
| 9 | iShares Russell 2000 Value ETF | 1.12M (0.74%) | 0.00 Increased by 0.00% | May 31, 25 |
| 10 | Iridian Value Opportunity CIT B | 1.04M (0.69%) | 0.00 Increased by 0.00% | Jun 30, 23 |
| 11 | iShares Biotechnology ETF | 985.25K (0.65%) | 8.42K Increased by +0.85% | Jul 31, 25 |
| 12 | State St Russell Sm/Mid Cp® Indx NL Cl C | 868.39K (0.58%) | 4.18K Increased by +0.48% | Apr 30, 25 |
| 13 | State St Russell Sm/Mid Cp® Indx SL Cl I | 868.39K (0.58%) | 0.00 Increased by 0.00% | Jul 31, 25 |
| 14 | Fidelity Extended Market Index | 830.56K (0.55%) | -2.17K Decreased by -0.26% | Jun 30, 25 |
| 15 | JPM Thematics Genetic Thrps C2 Acc USD | 777.30K (0.52%) | -23.26K Decreased by -2.99% | Oct 31, 24 |
| 16 | Fidelity® Extended Market Index | 741.47K (0.49%) | 48.84K Increased by +6.59% | Nov 30, 23 |
| 17 | Schwab US Small-Cap ETF™ | 718.23K (0.48%) | -364.00 Decreased by -0.05% | Jul 31, 25 |
| 18 | Vanguard Russell 2000 ETF | 712.79K (0.47%) | -50.82K Decreased by -7.13% | Jul 31, 25 |
| 19 | JPM Thematics Genetic Thrps C2 dist USD | 681.91K (0.45%) | -6.08K Decreased by -0.89% | Jul 31, 25 |
| 20 | State St Russell Sm Cap® Indx SL Cl I | 471.69K (0.31%) | 0.00 Increased by 0.00% | Jul 31, 25 |